Loxapine

Loxapine
Clinical data
Trade names	Loxitane, Adasuve
AHFS/Drugs.com	Monograph
MedlinePlus	a682311
License data	EU EMA: by INN; US DailyMed: Loxapine; US FDA: Loxapine;
Routes of; administration	By mouth, inhalation, intramuscular
Drug class	Antipsychotic
ATC code	N05AH01 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); BR: Class C1 (Other controlled substances); US: ℞-only; EU: Rx-only;
Pharmacokinetic data
Protein binding	96.8%
Metabolism	Extensive Liver; active metabolites include amoxapine and 8-hydroxyloxapine. Inhibits P-gp and is a substrate of CYP1A2, CYP3A4 and CYP2D6
Elimination half-life	4 hours (oral); 7.61 hours (inhalation)
Excretion	Majority are excreted within 24 hours, main route through urine (conjugated metabolites), small amounts through the feces (unconjugated metabolites)
Identifiers
	IUPAC name 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine;
CAS Number	1977-10-2 ;
PubChem CID	3964;
IUPHAR/BPS	205;
DrugBank	DB00408 ;
ChemSpider	3827 ;
UNII	LER583670J;
KEGG	D02340 ;
ChEBI	CHEBI:50841 ;
ChEMBL	ChEMBL831 ;
CompTox Dashboard (EPA)	DTXSID7023229 ;
ECHA InfoCard	100.016.215
Chemical and physical data
Formula	C18H18ClN3O
Molar mass	327.81 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	109 to 110 °C (228 to 230 °F)
	SMILES Clc2ccc1Oc4c(/N=C(\c1c2)N3CCN(C)CC3)cccc4;
	InChI InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3 ; Key:XJGVXQDUIWGIRW-UHFFFAOYSA-N ;
	(what is this?) (verify)

Loxapine, sold under the brand names Loxitane and Adasuve (inhalation only) among others, is a tricyclic antipsychotic medication used primarily in the treatment of schizophrenia. The medicine is a member of the dibenzoxazepine class and structurally very similar to clozapine. Several researchers have argued that loxapine, initially classified as a typical antipsychotic, behaves as an atypical antipsychotic.

Loxapine may be metabolized by N-demethylation to amoxapine, a tricyclic antidepressant.